Skip to content

BCBS Arkansas

Does BCBS Arkansas cover Zepbound?

Yes. BCBS Arkansas covers Zepbound for weight loss with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.

Policy document

  • Employer and ACA Marketplace: Covered with requirements. See the qualification pathways below.

Earliest policy review June 2, 2026. How we verify · Check your exact plan

Full requirements: Zepbound for Weight Loss (2 plan types)

Applies to Employer and ACA Marketplace plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

Obesity (BMI ≥ 30)

All of:

  • Adult patient (18+)
  • Participated in a comprehensive weight management program with behavioral modification, reduced-calorie diet, and increased physical activity with continuing follow-up for at least 6 months prior to drug therapy
  • Baseline BMI ≥ 30 kg/m2
  • Used with a reduced-calorie diet and increased physical activity

Overweight with comorbidity (BMI ≥ 27)

All of:

  • Adult patient (18+)
  • Participated in a comprehensive weight management program with behavioral modification, reduced-calorie diet, and increased physical activity with continuing follow-up for at least 6 months prior to drug therapy
  • Baseline BMI ≥ 27 kg/m2
  • Used with a reduced-calorie diet and increased physical activity

Plus any one of:

  • Hypertension
  • Type 2 diabetes mellitus
  • Dyslipidemia

Documentation to bring

  • Baseline BMI documentation (≥ 30 kg/m2 OR ≥ 27 kg/m2 with comorbidity; if transitioning from another weight loss drug, baseline BMI at start of any drug therapy)
  • Documentation of at least one weight-related comorbid condition if baseline BMI is ≥ 27 and < 30 kg/m2 (e.g., hypertension, type 2 diabetes mellitus, dyslipidemia)
  • Documentation of participation in a comprehensive weight management program (behavioral modification, reduced-calorie diet, increased physical activity with continuing follow-up) for at least 6 months prior to drug therapy

Quantity limits

  • 2.5mg/0.5mL, 5mg/0.5mL, 7.5mg/0.5mL, 10mg/0.5mL, 12.5mg/0.5mL, 15mg/0.5mL — 2 mL (4 pre-filled single-dose pens) / 21 days; 6 mL (12 pre-filled single-dose pens) / 63 days (84-day)
  • 2.5mg/0.6mL, 5mg/0.6mL, 7.5mg/0.6mL, 10mg/0.6mL, 12.5mg/0.6mL, 15mg/0.6mL — 2.4 mL (1 single-patient-use KwikPen) / 21 days; 7.2 mL (3 single-patient-use KwikPens) / 63 days (84-day)

Approval and renewal

  • Initial approval: 8 months
  • Renewal: every 12 months
  • Renewal: Patient must have completed at least 3 months of therapy at a stable maintenance dose AND lost at least 5% of baseline body weight OR continued to maintain their initial 5% weight loss. BMI and lifestyle program requirements are not re-verified at continuation.
  • Renewal: At least 12 weeks on therapy before the first renewal.

Not covered when

  • Coadministration with other tirzepatide-containing products is not recommended
  • Coadministration with any GLP-1 receptor agonist is not recommended
  • Vials are excluded (covered under LillyDirect manufacturer program)
  • OTC products are not included

Policy note: Baseline BMI is defined as BMI at the start of any drug therapy when patient is transitioning from another weight loss medication. The 28-day fill period uses 21-day supply and the 84-day fill period uses 63-day supply to allow time for refill processing.

verified June 2, 2026 · source: 6192 C Zepbound · View policy document (PDF)

Open on its own page →

Full requirements: Zepbound for Obstructive Sleep Apnea (OSA) (2 plan types)

Applies to Employer and ACA Marketplace plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

Moderate to severe OSA with obesity

All of:

  • Adult patient (18+)
  • Established diagnosis of moderate to severe OSA with AHI ≥ 15 events per hour on polysomnography (PSG) or home sleep apnea test (HSAT) with a technically adequate device
  • Current BMI ≥ 30 kg/m2
  • Used with a reduced-calorie diet and increased physical activity

Documentation to bring

  • Documentation of established diagnosis of moderate to severe OSA with AHI ≥ 15 events per hour on polysomnography (PSG) or home sleep apnea test (HSAT) with a technically adequate device
  • Current BMI documentation (≥ 30 kg/m2)

Quantity limits

  • 2.5mg/0.5mL, 5mg/0.5mL, 7.5mg/0.5mL, 10mg/0.5mL, 12.5mg/0.5mL, 15mg/0.5mL — 2 mL (4 pre-filled single-dose pens) / 21 days; 6 mL (12 pre-filled single-dose pens) / 63 days (84-day)
  • 2.5mg/0.6mL, 5mg/0.6mL, 7.5mg/0.6mL, 10mg/0.6mL, 12.5mg/0.6mL, 15mg/0.6mL — 2.4 mL (1 single-patient-use KwikPen) / 21 days; 7.2 mL (3 single-patient-use KwikPens) / 63 days (84-day)

Approval and renewal

  • Initial approval: 6 months
  • Renewal: every 12 months
  • Renewal: Patient must demonstrate a positive response to treatment from baseline evidenced by a decrease in OSA symptoms, and must be treated with a maintenance dosage based on individual treatment response and tolerability. OSA diagnosis (AHI ≥ 15) must be re-documented at continuation.

Not covered when

  • Coadministration with other tirzepatide-containing products is not recommended
  • Coadministration with any GLP-1 receptor agonist is not recommended
  • Vials are excluded (covered under LillyDirect manufacturer program)
  • OTC products are not included

Policy note: OSA must be moderate to severe (AHI ≥ 15 events/hour). No PAP/CPAP trial requirement is stated. Continuation requires documented decrease in OSA symptoms and treatment at a maintenance dose. The 28-day fill period uses 21-day supply and the 84-day fill period uses 63-day supply to allow time for refill processing.

verified June 2, 2026 · source: 6192 C Zepbound · View policy document (PDF)

Open on its own page →

Questions people ask
Does BCBS Arkansas cover Zepbound?
Yes. BCBS Arkansas covers Zepbound for weight loss with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.
How long does a Zepbound approval last with BCBS Arkansas?
Weight Loss — Applies to Employer and ACA Marketplace plans. Initial approval: 8 months. Renewal: every 12 months. Obstructive Sleep Apnea (OSA) — Applies to Employer and ACA Marketplace plans. Initial approval: 6 months. Renewal: every 12 months.
What does BCBS Arkansas require to renew Zepbound?
Weight Loss — Applies to Employer and ACA Marketplace plans. Patient must have completed at least 3 months of therapy at a stable maintenance dose AND lost at least 5% of baseline body weight OR continued to maintain their initial 5% weight loss. BMI and lifestyle program requirements are not re-verified at continuation. At least 12 weeks on therapy before the first renewal. Obstructive Sleep Apnea (OSA) — Applies to Employer and ACA Marketplace plans. Patient must demonstrate a positive response to treatment from baseline evidenced by a decrease in OSA symptoms, and must be treated with a maintenance dosage based on individual treatment response and tolerability. OSA diagnosis (AHI ≥ 15) must be re-documented at continuation.
How current is this information?
The oldest review date among the policies on this page is June 2, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

Also under BCBS Arkansas: Mounjaro, Ozempic, Wegovy

Zepbound under other plans: BCBS Alabama, BCBS Arizona, BCBS Massachusetts, BCBS Michigan, BCBS Minnesota, BCBS Nebraska, BCBS North Carolina, BCBS North Dakota

All insurance plans · All medications

Summary of BCBS Arkansas's written policy, not a guarantee of coverage. Plans vary by employer and benefit design.